Molecular medicine and neurodegenerative diseases
Abstract
A graphical abstract is available for this content
- This article is part of the themed collection: Molecular Medicine and Neurodegenerative Diseases
* Corresponding authors
a
Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA
E-mail:
chrischang@berkeley.edu
b Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA
c Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA
d
Department of Chemical Physiology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA
E-mail:
cravatt@scripps.edu
e
Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA
E-mail:
Doug.Johnson@pfizer.com
f
Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan 689-798, Korea
E-mail:
mhlim@unist.ac.kr
g Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA
A graphical abstract is available for this content
C. J. Chang, B. F. Cravatt, D. S. Johnson and M. H. Lim, Chem. Soc. Rev., 2014, 43, 6668 DOI: 10.1039/C4CS90065K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content